Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Dr. Stone is going to the moon! Eventually! After season 3 revealed post-apocalyptic science prodigy Senku Ishigami's ultimate goal of traveling to the lunar surface to reverse the process that ...

A Middlesex County Grand Jury indicted Dr. Derrick Todd for two counts of rape. Todd, who practiced at several locations including the Charles River Medical Associates in Framingham, allegedly ...

Vertex Pharmaceuticals' current market capitalization, exceeding $108 billion as of January 15, 2025, reflects strong investor confidence in its established cystic fibrosis (CF) franchise and its ...

Keith Speights has positions in Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Vertex Pharmaceuticals. The Motley Fool has a disclosure policy. Why This Beaten-Down Growth ...

The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $416.96, reflecting a -1.72% shift from the previouse trading day's closing. The stock's performance was behind ...

In a court filing on Monday, the Department of Health and Human Services fired back at Vertex Pharmaceuticals, standing by a directive that the biotech’s proposed fertility services program to go with ...

Vertex Pharmaceuticals (VRTX) comes in second with a score of 4.04 and a Buy rating given its dominance in the cystic fibrosis treatment category and diversified pipeline, making a compelling case ...